Search Results for “” – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Clinical outcomes Model

19 Publications found

Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia.

b

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

February 18, 2023

p COVID-19

c Clinical outcomes Model
Molecular-Guided Off-Label Targeted Therapy in a Large-Scale Precision Oncology Program.

b

JCO precision oncology

February 1, 2023

p Cancer

c Clinical outcomes Economics Highlighted Model
Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial.

b

The Lancet. Respiratory medicine

November 1, 2022

p COVID-19

c Clinical outcomes Guide Policy Making Highlighted Model RCT
Cost-Effectiveness of Tight Control for Crohn’s Disease With Adalimumab-Based Treatment: Economic Evaluation of the CALM Trial From a Canadian Perspective.

b

Journal of the Canadian Association of Gastroenterology

August 1, 2022

p Inflammatory Bowel Disease

c Clinical outcomes Economics Model
Cost-Effectiveness of the COVID-19 Test, Trace and Isolate Program in Colombia.

b

Lancet regional health. Americas

February 1, 2022

p COVID-19

c Clinical outcomes Economics Model
Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis.

b

Cost effectiveness and resource allocation : C/E

January 15, 2022

p COVID-19

c Clinical outcomes Economics Model
Antigen-based Rapid Diagnostic Testing or Alternatives for Diagnosis of Symptomatic COVID-19: A Simulation-based Net Benefit Analysis.

b

Epidemiology (Cambridge, Mass.)

November 1, 2021

p COVID-19

c Clinical outcomes Model
A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn’s Disease.

b

The American journal of gastroenterology

August 1, 2021

p Inflammatory Bowel Disease

c Clinical outcomes Economics Highlighted Model
Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn’s Disease.

b

Applied health economics and health policy

July 1, 2021

p Inflammatory Bowel Disease

c Clinical outcomes Economics Model
Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario.

b

BMC cancer

June 10, 2021

p Cancer

c Clinical outcomes Economics Model